Analyst Reco. Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
29.96 ^USD	+0.30%		-1.74%	+54.59%

22/03	North American Morning Briefing : Stocks Struggle After New Records	DJ
21/03	William Blair Initiates Neurogene With Outperform Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

William Blair Initiates Neurogene With Outperform Rating	21/03	MT
HC Wainwright Starts Neurogene With Buy Rating, $45 Price Target	08/01	MT
Stifel Starts Coverage on Neurogene with Buy Rating, $31 Price Target	05/01	MT
Mizuho Adjusts Price Target on Neoleukin Therapeutics to $1.50 From $2, Keeps Neutral Rating	09/23/09	MT
North American Morning Briefing : Stock Futures Dip as Higher Rate Fears Persist	09/23/09	DJ
Guggenheim Downgrades Neoleukin Therapeutics to Neutral From Buy	03/23/03	MT
Mizuho Downgrades Neoleukin Therapeutics to Neutral From Buy, Adjusts Price Target to $2 From $21	15/22/15	MT
Canaccord Genuity Downgrades Neoleukin Therapeutics to Hold From Buy, Adjusts Price Target to $1 From $10	15/22/15	MT
BofA Securities Downgrades Neoleukin Therapeutics to Underperform From Buy, Adjusts Price Target to $1 From $3	12/22/12	MT
HC Wainwright Adjusts Neoleukin Therapeutics' Price Target to $6 from $22, Maintains Buy Rating	12/22/12	MT
Stifel Nicolaus Adjusts Price Target for Neoleukin Therapeutics to $14 From $18, Maintains Buy Rating	11/22/11	MT
Canaccord Genuity Assumes Neoleukin Therapeutics at Buy with $10 Price Target	06/22/06	MT
Piper Sandler Adjusts Price Target on Neoleukin Therapeutics to $6 From $25, Reiterates Overweight Rating	31/22/31	MT
Guggenheim Adjusts Price Target for Neoleukin Therapeutics to $12 From $16, Maintains Buy Rating	10/22/10	MT
Piper Sandler Adjusts Neoleukin Therapeutics Price Target to $25 From $30, Maintains Overweight Rating	02/22/02	MT
NEOLEUKIN THERAPEUTICS : Piper Sandler Starts Neoleukin Therapeutics at Overweight with $30 Price Target	06/21/06	MT
NEOLEUKIN THERAPEUTICS : Stifel Starts Neoleukin Therapeutics at Buy With $18 Price Target	06/21/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer